On the smaller end of the scale, ARK sold 13,154 shares of Adaptive Biotechnologies Corp (NASDAQ: ADPT) through its ARKG ETF, ...

Investing.com -- Capricor Therapeutics Inc (NASDAQ: CAPR) stock tumbled 20.4% following news that two top FDA officials overseeing cell and gene therapies have been placed on administrative leave.

Investing.com -- Lipella Pharmaceuticals Inc (OTC: LIPO) stock plunged 23% after the clinical-stage biotechnology company was delisted from the Nasdaq Capital Market due to rule violations related to ...

The Company was notified by the Hearings Panel of its determination to delist the Company's common stock effective today.

Parataxis is launching a Bitcoin treasury platform for South Korean institutional investors, which saw Bridge Bio’s stock ...

However, RBC Capital has reiterated that Vertex could require stronger execution to adopt Alyftrek to justify the current ...

Zealand Pharma A/S’s shares have slid to a near 18-month low, as the Danish biotech’s experimental weight-loss drug faces mounting competition and a long wait ahead for crucial trial results.

The biotech sector has underperformed the overall market. Those are sentiments echoed by JPMorgan analyst Chris Schott, given ...

On the same day that FDA Commissioner Martin Makary spoke in a fireside chat during the 2025 Biotechnology Innovation Organization’s International Convention, the agency unveiled a pilot ...

The biotech firm filed its IPO paperwork May 23 in a bid to boost its finances, noting there was "substantial doubt" about ...

The cancer diagnostics and treatment company priced above its previously planned range and might signal a renewed appetite ...

BioNTech said in 2022 that it faced “threats of a groundless patent infringement suit” from a company that was “unable to ...